Arrowhead Pharmaceuticals Inc Cash Flow Quality Index

Latest as of March 2025: 1.25x

Arrowhead Pharmaceuticals Inc cash flow quality index. Arrowhead Pharmaceuticals Inc (ARWR) has a Cash Flow Quality Index of 1.25x as of March 2025. Operating cash flow of $460.05 Million exceeds net income of $367.86 Million, indicating high earnings quality where cash backs reported profits. See financial flexibility index of Arrowhead Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.25x
Operating CF / Net Income

Operating Cash Flow

$460.05 Million
USD

Net Income

$367.86 Million
USD

Data as of

Mar 2025
Most recent filing

Cash Flow Quality Index of Arrowhead Pharmaceuticals Inc (1999–2025)

Cash flow quality index of Arrowhead Pharmaceuticals Inc from 1999 to 2025. Historical Cash Flow Quality Index for Arrowhead Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Arrowhead Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.

Arrowhead Pharmaceuticals Inc Cash Flow Quality Index by Year (1999–2025)

Arrowhead Pharmaceuticals Inc cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for Arrowhead Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Arrowhead Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2025 5.96x $179.55 Million $30.11 Million ▲ +134.2%
2019 2.55x $173.03 Million $67.97 Million ▲ +100.0%
2012 -191754.63x $-15.34 Million $80.00 ▼ -322877598.6%
1999 -0.06x $-35.22K $593.00K —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.